Gsk Share Discussion Threads

[philanderer] 17/3/2017 09:23

17th march Berenberg buy tp 1890p up from 1850p

[maurillac] 16/3/2017 11:53

we seem to be need a nudge to push through 1690, c`mon chaps ;)
m

[philanderer] 16/3/2017 10:17

'Glaxo to pay first woman boss 25% less than male predecessor'

Emma Walmsley’s lack of experience cited as justification for salary

[philanderer] 15/3/2017 23:12

GlaxoSmithKline (GSK) Announces US Regulatory Submission Seeking Expanded Indication For Fluarix Quadrivalent (Influenza Vaccine) For Infants 6 Months And Older

[philanderer] 10/3/2017 13:25

10th march Kepler Cheuvreux initiates coverage with 'neutral' ..tp 1500p

[philanderer] 09/3/2017 09:36

9th march Jefferies buy tp 1900p up from 1800p

[philanderer] 08/3/2017 22:19

Coverage started today...

8th march Barclays equal weight tp 1550p

[tradermichael] 08/3/2017 09:41

NY Boy, 1715p should come, but it seems to be stuck in a mini-cycle somewhat below that level, and a return to >1700p may take a considerable time, so patience is required ...... ;0)

[ny boy] 07/3/2017 15:51

Mini dip today but I see 1715p coming up soon.

[ny boy] 05/3/2017 11:36

Heading to 1715p, not unexpected.

[toffeeman] 03/3/2017 12:04

Getting close to the 'S' point!

[philanderer] 02/3/2017 09:17

2nd march Credit Suisse neutral tp 1750p

reiterates

[ny boy] 24/2/2017 16:34

Strong close!

[essentialinvestor] 24/2/2017 15:22

Quickly bought back!.

[ny boy] 24/2/2017 15:20

Nice little bear trap to 1620p earlier!

[fangorn2] 24/2/2017 13:22

Bullish article on GSk...

Skim read it myself...but am sure Minerve might want to get their teeth into the financials

GlaxoSmithKline's Valuation Is Compelling

[ny boy] 24/2/2017 08:44

Creeping up a bit after the divi dive, which was expected and in line, on its best behavior, onwards to 1715p this quarter

[tradermichael] 24/2/2017 07:55

Onwards to the next good news (and there's always the dividends) ..... ;0)

[tradermichael] 24/2/2017 07:54

I'd rather this news wasn't released on ex div day ....

GlaxoSmithKline plc (LSE/NYSE:GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced positive headline results from a non-inferiority lung function study, which demonstrated that patients with well-controlled asthma were able to switch to the once-daily Relvar(R) Ellipta(R) (fluticasone furoate/vilanterol, FF/VI) 100/25, an inhaled corticosteroid (ICS)/long-acting beta(2) agonist (LABA) combination, from the twice-daily Seretide(R) Accuhaler(R) (fluticasone propionate /salmeterol, FP/SAL) 250/50, without compromising their lung function.

[fangorn2] 23/2/2017 14:12

Yup, Buy & tuck away for me as well...

Tempted to nibble some Astra Zeneca,Shire and Pfizer for drug expsoure.And a punt with some GW Pharms


GlaxoSmithKline hails success in asthma medication trial

[ny boy] 23/2/2017 08:42

Aye, buyers are keen to get in by the looks of things, nice long term hold for me and divi collections.

[tradermichael] 23/2/2017 07:38

The rise in share price from mid-January through February is real and realistic - not simply factoring in the dividend. Therefore, I do not expect any shrinking of the price by 23p to last for very long........ ;0)

[woodhawk] 22/2/2017 16:12

Divi is 23p.

[ny boy] 22/2/2017 15:50

Ex divi tomorrow. What's the drop 20/25p?